New strategies to improve both effectiveness and access to care  by Bruce, Martha L
Comment
490 www.thelancet.com/psychiatry   Vol 3   June 2016
New strategies to improve both eﬀ ectiveness and access to care
In The Lancet Psychiatry, Chris Salisbury and colleagues 
present their ﬁ ndings from a large, pragmatic 
trial testing the eﬀ ectiveness of integrating a 
multicomponent telehealth intervention into general 
practice for the treatment and management of 
depression.1 Depression was chosen as an exemplar 
of chronic disease: an episodic disorder that, although 
responsive to active treatments (medication or 
psychotherapy), often requires time to establish the 
most eﬀ ective regimen, ongoing management to 
maximise the likelihood of remission, and long-term 
maintenance treatment to minimise recurrence.2 
Despite this complexity, most depression is treated 
by general practitioners (GPs) who commonly 
prescribe antidepressants, but might not have the 
time, workforce, or resources to provide optimum 
ongoing treatment and management.3 Thus, despite 
a large evidence base for depression treatment and 
management, many individuals with depression lack 
access to eﬀ ective care.4,5
The study ﬁ ndings show the promise of technology to 
improve the reach and eﬀ ectiveness of chronic disease 
management while potentially reducing the burden 
on GPs. The intervention is unique by both combining 
several evidence-based telehealth strategies for 
depression treatment (eg, online cognitive behavioural 
therapy) and management (eg, telephone-based 
motivational interviewing) into a single package and 
by integrating the intervention into routine general 
practice. The programme is tailored to each participant’s 
needs and preferences. Thus telehealth oﬀ ers more 
patients more access to more options than have 
previously been available.
Implementation of this complex intervention for 
participants recruited from 43 general practices is a 
remarkable accomplishment. Indeed, implementation 
of even simple interventions into routine practice 
in a single setting is challenging. This challenge is 
compounded by the need for a research methodology 
to demonstrate eﬀ ectiveness. The investigators 
used the practices’ shared electronic medical records 
(EMRs) to identify potentially eligible patients and 
draw a random sample, thereby increasing the study’s 
potential generalisability. The study recruited and 
randomly assigned an impressively large sample of 
609 participants who reported clinically signiﬁ cant 
symptoms and met diagnostic criteria and 85% of 
participants were retained during 1 year. The results 
showed that patients randomly assigned to the 
telehealth intervention had more rapid improvement 
in depression severity than did patients receiving usual 
care. After 4 months, 68 (27%) of 255 participants 
who received the telehealth intervention responded to 
treatment, compared with 50 (19%) of 270 participants 
in the usual care group (adjusted odds ratio 1·7, 95% CI 
1·1–2·5, p=0·019).
Does it matter who these participants were? The 
research team initially contacted 16 570 patients who 
met the EMR eligibility criteria and were approved by 
their GP. However, only 2375 patients (14%) expressed 
interest in participating. Most eﬃ  cacy trials, especially 
medication treatment studies, focus on outcomes 
with an expectation that the results will be broadly 
generalisable. However, the recruitment methodology 
(eg, advertisements or clinician referral) is almost 
guaranteed to accrue a sample that diﬀ ers from the 
population at large.6
If interventions are to be developed that are both 
eﬀ ective across the general population and improve 
access to care, then understanding of the extent to 
which participants represent the wider target population 
is important. And if participants are not representative, 
it is useful to know whether the factors that aﬀ ect study 
non-participation are also relevant to eﬀ ectiveness and 
access to care. For example, did these individuals think 
their depressive symptoms were unimportant? Or that 
their current treatment was suﬃ  cient? Or were they 
reluctant to enrol in research? Or were they reluctant to 
participate in telehealth? Such reluctance might not be a 
problem if the goal of telehealth is to serve only a small 
subset of patients. However, if the goal is to improve 
access to care and reduce burden on general practices, 
then the intervention should be acceptable and 
feasible to as many eligible patients as possible. Thus 
information about how patients (including those who 
decline to participate) perceive telehealth is important. 
At the same time, telehealth might still be novel enough 
to expect only early adopters to participate. Most people 
who currently use once-innovative practices (such 
as smartphones or Facebook or online dating) only 
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Mental health services have an important role in the 
treatment of people at risk of suicide. Many people 
who attempt suicide have underlying mental health 
problems, and the treatment of these issues is crucial to 
reduce their suicide risk. In other areas of medicine, since 
the publication of the landmark report To Err is Human,1 
there have been sustained eﬀ orts to reduce adverse 
events associated with health care.1,2 Internationally, an 
awareness has budded that eﬀ ective clinical governance 
is a vital component of high-quality health care.3–6
Kapur and colleagues7 bring the health care, clinical 
governance, and suicide prevention strands together. 
Their Article examines how hospital organisational 
factors and the quality of services oﬀ ered to patients 
who use mental health services relate to suicide 
prevention. The study used data from several sources. 
The National Conﬁ dential Inquiry into Suicide and 
Homicide by People with Mental Illness8 was used to access 
information about people who died by suicide within 
12 months of contact with a mental health service. 
Relevant suicide rates were calculated using a count 
of all people in contact with mental health services 
as the denominator. To gauge the extent to which 
service changes were associated with these suicide 
rates, the authors surveyed the medical directors of all 
mental health services in the National Health Service 
in England. The survey examined the adoption of 
16 policies and procedures that related to ward safety 
(eg, removing non-collapsible curtain rails), availability 
of community services (eg, placing an assertive outreach 
team within community health services), staﬀ  training 
(eg, training clinical staﬀ  in suicide risk management), 
adoption of speciﬁ c policies (eg, policy regarding 
response to inpatients who abscond), and adoption of 
did so after the ﬁ rst wave of adopters had conﬁ rmed 
their value. From that perspective, information about 
patients’ reluctance to participate in telehealth would be 
useful—not as an indicator of the intervention’s future 
reach, but as a barometer of the work needed to increase 
the acceptability of telehealth once eﬀ ectiveness has 
been demonstrated.
Because participants were randomly assigned to 
treatment, factors aﬀ ecting non-participation might 
not bias the eﬀ ectiveness data, but they could restrict 
generalisability. For studies testing new strategies 
for the implementation of evidence-based practices 
aiming to optimise both eﬀ ectiveness and access, 
minimisation of selection bias takes on a greater 
importance. Alternative study designs might better ﬁ t 
these goals. For example, trials that compare evidence-
based interventions or test new implementation 
strategies might beneﬁ t from designs in which the unit 
of randomisation is a cluster (eg, clinician or practice) 
and the intervention becomes the standard of care for 
general practice.7,8 Such designs could make it possible 
to separate research participation from intervention 
participation and to inform the reasons that patients 
do or do not participate in each. And eﬀ ectiveness can 
be assessed in both research patients (using research 
measures) and the patient populations as a whole (using 
de-identiﬁ ed medical records). These and other designs 
might help to optimise research on interventions 
designed to improve access to evidence-based care.
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Reducing suicide through improved quality of care
